Preview Mode Links will not work in preview mode

Oct 4, 2022

Featuring an interview with Dr Michael Birrer, including the following topics:

  • Prologue (0:00)
  • Multidisciplinary Management of Endometrial Cancer in Copenhagen, Denmark; Boston, Massachusetts and Little Rock, Arkansas (6:17)
  • Subtypes of Endometrial Cancer (12:51)
  • Treatment for Microsatellite Instability-High...


Sep 29, 2022

Featuring a slide presentation and related discussion from Dr Amrita Krishnan, including the following topics:

  • Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
  • Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
  • Belantamab...


Sep 29, 2022

Featuring an interview with Dr Amrita Krishnan, including the following topics:

  • Case: A woman in her early 60s who presents with renal failure and receives CyBorD for multiple myeloma (MM) (0:00)
  • Dyspnea associated with carfilzomib; ocular toxicity with belantamab mafodotin (6:26)
  • Efficacy, tolerability and sequencing...


Sep 26, 2022

Featuring an interview with Dr Heather Wakelee, including the following topics:

  • Similarities and differences in the efficacy of neoadjuvant and adjuvant immunotherapies for localized non-small cell lung cancer (NSCLC) (0:00)
  • Available data on the treatment of patients whose disease relapses on or after adjuvant...


Sep 26, 2022

Featuring a slide presentation and related discussion from Dr Heather Wakelee, including the following topics:

  • Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
  • Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
  • Belantamab...